1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst?s Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Product (Current size & future market estimates)
5.1. Consumables
5.2. Instruments
5.3. Software and Services
6. Market Outlook by Technology (Current size & future market estimates)
6.1. Culture-based
6.2. Molecular
6.3 Proteomic
7. Market Outlook by Technique (Current size & future market estimates)
7.1. Conventional
7.2. Automated
8. Market Outlook by Application (Current size & future market estimates)
8.1. Bacterial Infections
8.2. Fungal Infections
8.3. Mycobacterial Infections
9. Market Outlook by End use (Current size & future market estimates)
9.1. Hospital Laboratories
9.2. Reference Laboratories
9.3. Others
10. Market Outlook by Regions (Current size & future market estimates)
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.3. Asia Pacific
10.3.1. Japan
10.3.2. China
10.3.3. India
10.4. Latin America
10.4.1. Brazil
10.4.2. Mexico
10.5. MEA
10.5.1. South Africa
11. Competitive Landscape
11.1. Market Share/Market Ranking Analysis
11.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
12. Company Profiles
ncludes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
12.1. Becton, Dickinson and Company
12.2. bioM�rieux SA
12.3. Thermo Fisher Scientific, Inc.
12.4. Danaher
12.5. Luminex Corporation
12.6. F. Hoffmann-La Roche Ltd
12.7. Bruker Corporation
12.8. Abbott Laboratories
12.9. Abtek Biologicals Ltd.
12.10. Autobio Diagnostics Co., Ltd.